Small Cap Breakfast
Set menu
AIM:
Total number of AIM Companies (Incl Susp):
956*
Total number of AIM Companies trading:
907*
*as at close of business 15 March 2018
Standard List** of Main Market:
Total number of Standard List Companies
(Incl Susp):
136*
Total number of Standard List Companies trading:
123*
*as at close of business 15 March 2018
NEX Growth Market:
Total number of NEX Growth Market Companies (Incl Susp):
88*
Total number of NEX Growth Market Companies trading:
82*
*as at close of business 15 March 2018
*A corporate client of Hybridan LLP
** Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity
Dish of the day
No Joiners Today
Off the menu
Graphene Nanochem has left AIM but hopes to IPO again in due course subject to completing an acquisition.
Breakfast buffet
NetScientific (LON:NSCI) 53.5p £36.94m
The transatlantic healthcare IP commercialisation Group, announces that Wanda Health, its portfolio company, is expanding into orthopedics through a new partnership with HRS Home Health ("HRS").
Wanda's predictive analytics and artificial intelligence solutions already provide remote management solutions for chronic conditions in heart and respiratory health. The partnership with HRS, a Wanda client, brings Wanda's capabilities to bear on orthopedics, and initial pilot studies have demonstrated a decrease in the length of time patients were required to remain in hospital through the use of Wanda's technology. HRS will use Wanda Telehealth and Predictive Analytics to provide real-time data and informatics to orthopedic surgeons and their clinical teams.
CentralNic Group (LON:CNIC) 58p £6m
“The global software platform company supporting subscription web services including domain names, announce that it has secured the distribution contract for the Top Level Domain .ooo from Infibeam Incorporation Limited, an e-commerce conglomerate company listed on the India Stock Exchange (BSE/NSE) with a market capitalisation of over $1bn.
In the fast growing e-commerce industry, Infibeam operates a unique business model with a mix of Infibeam's shopping destination and Infibeam Web Services, which include an online ecommerce platform, payments, logistics and digital marketing to merchants globally. The .ooo registry business places Infibeam in a strong position as an exciting new affordable alternative to .com tailor-made for large-scale usage in existing and emerging markets, along with being a digital transformation tool for existing businesses to find online markets and for new business ideas to be realised. In addition to this, in Russia and other markets, "ooo" is a common abbreviation for "Limited Liability Company."“ FYDec18E rev £28.5m and PBT £6.7m. PE c.11x.
APC Tech Group (LON:APC) 7.75p £10.46m
Some recent business milestones from the e provider of design-in, specification and distribution services for specialist electronic components and systems, lighting technologies and connectivity products.
“APC's lighting division has celebrated completing its 500th lighting installation project since it was acquired by APC in 2013. The 500 projects span 268 customers within retail, leisure, commercial real estate, warehousing and logistics and equate to 420,000 LED luminaires supplied and installed, generating £38.5 million in revenue. The division is now firmly established as a provider of turnkey lighting solutions to property and facility management companies.
Elsewhere across the business, APC Hi-Rel, supplier of high reliability components to aerospace and defence, has been named in the top 2% of BAE Systems' electronic systems sector suppliers at the BAE Partner 2 Win symposium in America on 6th March 2018. The event recognised BAE's best-in-class suppliers based on quality and delivery.” FYAug18E rev £17.5m and £0.68m PBT
Petards Group* (LON:PEG) 27p £15.06m
“The software developer of advanced security and surveillance systems, is pleased to announce that the Ministry of Defence (MOD) has exercised its option to extend the existing three year contract announced on 22 December 2016, from the Air Platform Systems Platform Protection team, part of the UK MOD, worth in excess of £1.6m for a further two years to 31 Dec 2021, for the support of ALE 47 and M147 Threat Adaptive Countermeasures Dispensing Systems which are fitted to Lynx, Puma, Chinook, Merlin, and C130J aircraft platforms.
Under the terms of the contract Petards will continue to perform Post Design Services, with additional engineering, repair, refurbishment and manufacturing which are expected to significantly enhance the value of the agreement.
The contract extension is expected to be worth in excess of £1.1m over the two year period to 31 Dec 2021 in addition to the original contract which was worth in excess of £1.6m for the three year period to 31 Dec 2019. “
Pacific Industrial & Logistics REIT (LON:PILR) 119.5p £81.4m
Proposed £50m placing to fund the acquisition of a pipeline of UK urban logistics assets with a gross acquisition cost of £73.6m. Pricing TBA
“The Placing and Acquisition support the Company's strategy to build a specialist portfolio of high-quality, last mile and regional (sub-£10m) single-let urban logistics assets in the UK. Tenant demand in the Company's chosen sub-sector remains strong as occupiers address the challenges of e-commerce, modern logistics and evolving infrastructure demands. “
Based on the capital raising proceeding and completion of the acquisitions, the Company is targeting a dividend yield and total returns, once fully invested and on a full year basis, in line with investment policy guidance in excess of 6% and 10% - 15% respectively.
Accrol Group (LON:ACRL) 13p £36.12m
“Further to the information provided in the Half Year Results announced on 22 January 2018, the Board of Accrol provides the following update. Financial key points. Adjusted EBITDA loss for year ending 30 Apr 2018 ("FY18") now expected to be in the region of £5m
Net debt at 30 Apr 2018 expected to be circa £34m
Constructive discussion with the Group's bank on headroom and resetting covenants
Outlook for year ending 30 Apr 2019 ("FY19") remains in line with market expectations
New volume growth positively impacting Q1 for year ending 30 April 2019 along with strengthening margins across customer portfolio
FY18 Profit after tax, before any asset impairment charges, expected to be a loss of £13m
Non-cash impairments likely due to restructuring plans and potential related intangibles write downs” Accrol is tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers. We could see no forecasts.
WideCells (LON:WDC) 11.9p £7.7m
WideCells’ “100% owned stem cell storage and research division, WideCells Ltd, has been granted a government-backed Innovate UK Knowledge Transfer Partnership with Manchester Metropolitan University (MMU) to undertake research on a new form of stem cell technology. As part of this three-year research project, Innovate UK will provide £156,000 worth of funding towards a total project cost of £234,000.
The new technology allows specialised adult cells such as skin cells to be genetically reprogrammed to assume a stem cell-like state and accordingly be used in stem cell treatment and in the study of disease. These stem cells, known as induced pluripotent stem cells (iPSCs), could revolutionise the stem cell industry by making stem cells, and subsequently stem cell treatments, much more accessible. Following the research project, WideCells hope to have advanced iPSCs to a point of commercialisation so that the technology can be included in the Group's end-to-end stem cell service offering. ”
Mereo BioPharma (LON:MPH) 310p £208m
The “multi-asset biopharmaceutical company focused on the acquisition, development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases, today announced positive top-line results from a Phase 2b dose-ranging study with BGS-649 for the treatment of hypogonadotropic hypogonadism (HH) in men with a body mass index of over 30. BGS-649 is a once weekly oral aromatase inhibitor designed to restore a patient's own testosterone to normal levels by inhibiting the conversion of testosterone to oestradiol.
The study met its primary endpoint, normalizing total testosterone levels in over 75% of subjects after 24 weeks of treatment (p<0.001 versus placebo for each of the three doses tested), and its secondary endpoint of normalizing testosterone in at least 90% of patients after 24 weeks, which occurred at the two highest doses.”
Staffline Group (LON:STAF) 950p £264.6m
“The Recruitment and Employability organisation, announces that on 16 Mar 2018, it completed the acquisition of Endeavour Group Limited and its subsidiary Vital Recruitment Limited. Vital was incorporated in 2006 and is a leading blue-collar recruitment business in the East of England, focusing on the Food, Agriculture and Logistics sectors. The acquisition will significantly increase Staffline's scale and presence in the East of England, supplementing the Group's existing Food and Agriculture offerings in that area. Audited accounts for the year to March 2017 show that Endeavour had a turnover of £83m and a PBT of £0.5m.
The acquisition is expected to be earnings neutral in the current year and is being funded out of Staffline's existing resources.” FYDec18E PBT £32.42. PE c.8x. Yield c.3%.